Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICE: Everolimus with Cetuximab and Irinotecan in mCRC
NCT01387880Phase 2Completed
- Sponsor
- Herlev Hospital
- Start
- Jan 2010
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in metastatic colorectal cancer (mCRC), sponsored by Herlev Hospital. Started Jan 2010; status: completed.
02
Drugs
everolimus
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01387880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01387880.